Dudediligence.

Monopar Therapeutics Inc

MNPRNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$6,362,756

7 notices · 70,442 sh

Oct 2025 to Oct 2026

Reported ·

$343,889

2 sales · 1 buy · $104,925 bought

Oct 2025 to Jun 2026

The two figures cover different periods.

None of the 2 reported sales carry the 10b5-1 box. Together they are 0.08% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-10-01: CHRISTOPHER STARR, Form 1442026-09-24: CHANDLER ROBINSON, Form 1442026-08-26: PATRICE RIOUX, Form 1442026-08-26: KIM TSUCHIMOTO, Form 1442026-08-25: RAYMOND WILLIAM ANDERSON, Form 1442026-07-08: Arthur Klausner, Form 1442025-12-18: Arthur Klausner, Form 1442025-12-18: KLAUSNER ARTHUR J, sold2025-12-26: Vu Quan Anh, bought
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-10-01CHRISTOPHER STARR, Director$1,338,456
16,800 shplan 2026-05-28Form 4s on file end Jun 23144 ↗
2026-09-24CHANDLER ROBINSON, Chief Executive Officer$2,597,025
29,056 shplan 2026-06-25Form 4s on file end Jun 23144 ↗
2026-08-26PATRICE RIOUX, Acting Chief Medical Officer$111
1 shplan 2026-05-27Form 4s on file end Jun 23144 ↗
2026-08-26KIM TSUCHIMOTO, Director$906,508
8,180 shplan 2026-05-27Form 4s on file end Jun 23144 ↗
2026-08-25RAYMOND WILLIAM ANDERSON, Director$699,786
6,284 shplan 2026-05-26Form 4s on file end Jun 23144 ↗
2026-07-08Arthur Klausner, Former Board Member$476,967
5,000 shno plan dateForm 4s on file end Jun 23144 ↗
2025-12-18Arthur Klausner, Board Member$343,903
5,121 shno plan date144 ↗
Form 4, 2025-12-19: sold 5,121 at $67.15 Form 4 ↗